A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

Writing for SBM these days is a bit like being in one of those cash grab machines, though instead of money flying over the ...

U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...

US Health and Human Services Secretary Robert F. Kennedy Jr. has repeatedly claimed in public statements that most vaccines ...

Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joins Bob Sirott to talk about the latest health news. Dr. Marty discusses two new COVID vaccines ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...

SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...

US growth likely to slow to 1.6% this year, hobbled by Trump's trade wars, OECD says. U.S. economic growth will slow to 1.6% this year from 2.8% last year as President ...

Moderna MRNA announced the FDA approval for mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine, though for a ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...